Julie Greenlees

Julie Greenlees, MS, is an experienced professional in drug safety and pharmacovigilance operations, currently serving as Director, Drug Safety & Pharmacovigilance Operations at Sage Therapeutics since December 2017. Julie has held various roles in the industry, including Associate Director at Sage Therapeutics and Manager of Pharmacovigilance Operations at Karyopharm Therapeutics Inc. In addition to these positions, Julie is a Cambridge Founding Member at Grapevine. Prior roles include PV Scientist Development Lead at Shire, Senior Pharmacovigilance Specialist at Vertex Pharmaceuticals, and Global Patient Safety & Risk Management Specialist at Sanofi Genzyme. Julie holds a Master of Science in Regulatory Affairs from Northeastern University and a Bachelor of Science in Forensic Science and Chemistry from the University of New Haven.